Cargando…

Solid cancer: the new tumour spread endpoint opens novel opportunities

Novel androgen deprivation agents delay metastasis in non-metastatic, castration-resistant, prostate cancer (nmCRPC). The recent regulatory guidance: considerations for metastasis-free survival endpoint in clinical trials, opens new opportunities in cell biology, medicinal chemistry and advanced ima...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernandes, Michael, Rosel, Daniel, Brábek, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889500/ https://www.ncbi.nlm.nih.gov/pubmed/31427682 http://dx.doi.org/10.1038/s41416-019-0536-0

Ejemplares similares

Pragmatic medicine in solid cancer: a translational alternative to precision medicine
por: Brábek, Jan, et al.
Publicado: (2016)

Drugs for solid cancer: the productivity crisis prompts a rethink
por: Rösel, Daniel, et al.
Publicado: (2013)

Exploring Novel Endpoints for Clinical Trials in Kidney Disease: Challenges and Opportunities
por: Roy-Chaudhury, Prabir
Publicado: (2017)

The Role of IL-6 in Cancer Cell Invasiveness and Metastasis—Overview and Therapeutic Opportunities
por: Rašková, Magdalena, et al.
Publicado: (2022)

Cell polarity signaling in the plasticity of cancer cell invasiveness
por: Gandalovičová, Aneta, et al.
Publicado: (2016)

A Screen for PKN3 Substrates Reveals an Activating Phosphorylation of ARHGAP18
por: Dibus, Michal, et al.
Publicado: (2020)

Quantitative phase imaging unravels new insight into dynamics of mesenchymal and amoeboid cancer cell invasion
por: Tolde, Ondřej, et al.
Publicado: (2018)

The role of the tissue microenvironment in the regulation of cancer cell motility and invasion
por: Brábek, Jan, et al.
Publicado: (2010)

SH3 Domain Tyrosine Phosphorylation – Sites, Role and Evolution
por: Tatárová, Zuzana, et al.
Publicado: (2012)

Cytoplasmic Tail of MT1-MMP: A Hub of MT1-MMP Regulation and Function
por: Strouhalova, Katerina, et al.
Publicado: (2023)

Vimentin Intermediate Filaments as Potential Target for Cancer Treatment
por: Strouhalova, Katerina, et al.
Publicado: (2020)

Antiretroviral pre-exposure prophylaxis: A new opportunity to slow HIV spread in India
por: Mayer, Kenneth H., et al.
Publicado: (2016)

The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells
por: Paňková, K., et al.
Publicado: (2009)

The interaction of p130Cas with PKN3 promotes malignant growth
por: Gemperle, Jakub, et al.
Publicado: (2018)

The emerging role of microtubules in invasion plasticity
por: Legátová, Anna, et al.
Publicado: (2023)

PKCα promotes the mesenchymal to amoeboid transition and increases cancer cell invasiveness
por: Vaškovičová, Katarína, et al.
Publicado: (2015)

Are We Ready for Migrastatics?
por: Solomon, Jonathan, et al.
Publicado: (2021)

High-throughput transcriptomic and proteomic profiling of mesenchymal-amoeboid transition in 3D collagen
por: Čermák, Vladimír, et al.
Publicado: (2020)

The Importance of Endpoints in Oncology Clinical Trials
por: Faiman, Beth
Publicado: (2023)

Structural characterization of CAS SH3 domain selectivity and regulation reveals new CAS interaction partners
por: Gemperle, Jakub, et al.
Publicado: (2017)

Sustained Inflammatory Signalling through Stat1/Stat2/IRF9 Is Associated with Amoeboid Phenotype of Melanoma Cells
por: Gandalovičová, Aneta, et al.
Publicado: (2020)

Invadopodia Structure in 3D Environment Resolved by Near-Infrared Branding Protocol Combining Correlative Confocal and FIB-SEM Microscopy
por: Dalecká, Markéta, et al.
Publicado: (2021)

Surrogate endpoints… Uncommon for a common man!
por: Kumar, Ashish
Publicado: (2019)

Opening windows of opportunity for smoking cessation treatment
por: Castellano, Maria Vera Cruz de Oliveira
Publicado: (2018)

Migrastatics—Anti-metastatic and Anti-invasion Drugs: Promises and Challenges
por: Gandalovičová, Aneta, et al.
Publicado: (2017)

New Opportunities
por: Heintzel, Alexander
Publicado: (2020)

Invasive cells in animals and plants: searching for LECA machineries in later eukaryotic life
por: Vaškovičová, Katarína, et al.
Publicado: (2013)

RNA-seq of macrophages of amoeboid or mesenchymal migratory phenotype due to specific structure of environment
por: Čermák, Vladimír, et al.
Publicado: (2018)

Residual disease and immune infiltration as a new surrogate endpoint for TNBC post neoadjuvant chemotherapy
por: Luen, Stephen L., et al.
Publicado: (2019)

Phosphorylation of tyrosine 90 in SH3 domain is a new regulatory switch controlling Src kinase
por: Koudelková, Lenka, et al.
Publicado: (2023)

Open science for nutrition and physical activity research: a new challenge and lots of opportunities for IJBNPA
por: Jago, Russell, et al.
Publicado: (2018)

Metastasis of aggressive amoeboid sarcoma cells is dependent on Rho/ROCK/MLC signaling
por: Kosla, Jan, et al.
Publicado: (2013)

BJPsych Open editorial transition: opportunity, challenge and vision
por: Kaufman, Kenneth R.
Publicado: (2018)

Tyrosine phosphorylation within the SH3 domain regulates CAS subcellular localization, cell migration, and invasiveness
por: Janoštiak, Radoslav, et al.
Publicado: (2011)

New Jersey’s Opportunity
Publicado: (1900)

TLR4-Mediated Recognition of Mouse Polyomavirus Promotes Cancer-Associated Fibroblast-Like Phenotype and Cell Invasiveness
por: Janovec, Vaclav, et al.
Publicado: (2021)

Tumour vessel remodelling: new opportunities in cancer treatment
por: Ganss, Ruth
Publicado: (2020)

Endpoint surrogacy in oncology Phase 3 randomised controlled trials
por: Zhang, Jianrong, et al.
Publicado: (2020)

The Fatigue Severity Scale in Interstitial Lung Disease: An Energizing Endpoint
por: Wong, Alyson W., et al.
Publicado: (2023)

Increased Level of Long Non-Coding RNA MALAT1 Is a Common Feature of Amoeboid Invasion
por: Merta, Ladislav, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9elosljp6b8s01brq8s80k1u8u